-
Signature
-
/s/ Michael Hom, Attorney-in-Fact
-
Issuer symbol
-
FGEN
-
Transactions as of
-
06 Jun 2025
-
Transactions value $
-
-$1,041
-
Form type
-
4
-
Filing time
-
09 Sep 2025, 19:26:15 UTC
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| DeLucia David |
Chief Financial Officer |
C/O FIBROGEN, INC., 350 BAY STREET, SUITE 100 # 6009, SAN FRANCISCO |
/s/ Michael Hom, Attorney-in-Fact |
09 Sep 2025 |
0002040705 |
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
FGEN |
Common Stock |
Tax liability |
-$399 |
-51 |
-1.1% |
$7.83 |
4.59K |
06 Jun 2025 |
Direct |
F1 |
| transaction |
FGEN |
Common Stock |
Tax liability |
-$641 |
-53 |
-1.15% |
$12.10 |
4.54K |
06 Sep 2025 |
Direct |
F1 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Explanation of Responses:
Remarks:
Share amount and share prices reflect a 1-for-25 reverse stock split effective on June 16, 2025.